Cargando…

Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?

In obesity, several epigenetic modifications, including histones remodeling, DNA methylation, and microRNAs, could accumulate and determine increased expression of inflammatory molecules, the adipokines, that in turn might induce or accelerate the onset and development of cardiovascular and metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontanella, Rosaria Anna, Scisciola, Lucia, Rizzo, Maria Rosaria, Surina, Surina, Sardu, Celestino, Marfella, Raffaele, Paolisso, Giuseppe, Barbieri, Michelangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639875/
https://www.ncbi.nlm.nih.gov/pubmed/34869683
http://dx.doi.org/10.3389/fcvm.2021.768026
_version_ 1784609221399019520
author Fontanella, Rosaria Anna
Scisciola, Lucia
Rizzo, Maria Rosaria
Surina, Surina
Sardu, Celestino
Marfella, Raffaele
Paolisso, Giuseppe
Barbieri, Michelangela
author_facet Fontanella, Rosaria Anna
Scisciola, Lucia
Rizzo, Maria Rosaria
Surina, Surina
Sardu, Celestino
Marfella, Raffaele
Paolisso, Giuseppe
Barbieri, Michelangela
author_sort Fontanella, Rosaria Anna
collection PubMed
description In obesity, several epigenetic modifications, including histones remodeling, DNA methylation, and microRNAs, could accumulate and determine increased expression of inflammatory molecules, the adipokines, that in turn might induce or accelerate the onset and development of cardiovascular and metabolic disorders. In order to better clarify the potential epigenetic mechanisms underlying the modulation of the inflammatory response by adipokines, the DNA methylation profile in peripheral leukocytes of the promoter region of IL-6 and NF-kB genes and plasma miRNA-21 levels were evaluated in 356 healthy subjects, using quantitative pyrosequencing-based analysis, and correlated with plasma adiponectin levels, body fat content and the primary pro-inflammatory markers. In addition, correlation analysis of DNA methylation profiles and miRNA-21 plasma levels with intima-media thickness (IMT), a surrogate marker for early atherosclerosis, left ventricular mass (LVM), left ventricular ejection fraction (LVEF), and cardiac performance index (MPI) was also performed to evaluate any potential clinical implication in terms of cardiovascular outcome. Results achieved confirmed the role of epigenetics in the obesity-related cardiovascular complications and firstly supported the potential role of plasma miRNA-21 and IL-6 and NF-kB DNA methylation changes in nucleated blood cells as potential biomarkers for predicting cardiovascular risk in obesity. Furthermore, our results, showing a role of adiponectin in preventing epigenetic modification induced by increased adipose tissue content in obese subjects, provide new evidence of an additional mechanism underlying the anti-inflammatory properties and the cardiovascular benefits of adiponectin. The exact mechanisms underlying the obesity-related epigenetic modifications found in the blood cells and whether similar epigenetic changes reflect adipose and myocardial tissue modifications need to be further investigated in future experiments.
format Online
Article
Text
id pubmed-8639875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86398752021-12-04 Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? Fontanella, Rosaria Anna Scisciola, Lucia Rizzo, Maria Rosaria Surina, Surina Sardu, Celestino Marfella, Raffaele Paolisso, Giuseppe Barbieri, Michelangela Front Cardiovasc Med Cardiovascular Medicine In obesity, several epigenetic modifications, including histones remodeling, DNA methylation, and microRNAs, could accumulate and determine increased expression of inflammatory molecules, the adipokines, that in turn might induce or accelerate the onset and development of cardiovascular and metabolic disorders. In order to better clarify the potential epigenetic mechanisms underlying the modulation of the inflammatory response by adipokines, the DNA methylation profile in peripheral leukocytes of the promoter region of IL-6 and NF-kB genes and plasma miRNA-21 levels were evaluated in 356 healthy subjects, using quantitative pyrosequencing-based analysis, and correlated with plasma adiponectin levels, body fat content and the primary pro-inflammatory markers. In addition, correlation analysis of DNA methylation profiles and miRNA-21 plasma levels with intima-media thickness (IMT), a surrogate marker for early atherosclerosis, left ventricular mass (LVM), left ventricular ejection fraction (LVEF), and cardiac performance index (MPI) was also performed to evaluate any potential clinical implication in terms of cardiovascular outcome. Results achieved confirmed the role of epigenetics in the obesity-related cardiovascular complications and firstly supported the potential role of plasma miRNA-21 and IL-6 and NF-kB DNA methylation changes in nucleated blood cells as potential biomarkers for predicting cardiovascular risk in obesity. Furthermore, our results, showing a role of adiponectin in preventing epigenetic modification induced by increased adipose tissue content in obese subjects, provide new evidence of an additional mechanism underlying the anti-inflammatory properties and the cardiovascular benefits of adiponectin. The exact mechanisms underlying the obesity-related epigenetic modifications found in the blood cells and whether similar epigenetic changes reflect adipose and myocardial tissue modifications need to be further investigated in future experiments. Frontiers Media S.A. 2021-11-19 /pmc/articles/PMC8639875/ /pubmed/34869683 http://dx.doi.org/10.3389/fcvm.2021.768026 Text en Copyright © 2021 Fontanella, Scisciola, Rizzo, Surina, Sardu, Marfella, Paolisso and Barbieri. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Fontanella, Rosaria Anna
Scisciola, Lucia
Rizzo, Maria Rosaria
Surina, Surina
Sardu, Celestino
Marfella, Raffaele
Paolisso, Giuseppe
Barbieri, Michelangela
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title_full Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title_fullStr Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title_full_unstemmed Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title_short Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
title_sort adiponectin related vascular and cardiac benefits in obesity: is there a role for an epigenetically regulated mechanism?
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639875/
https://www.ncbi.nlm.nih.gov/pubmed/34869683
http://dx.doi.org/10.3389/fcvm.2021.768026
work_keys_str_mv AT fontanellarosariaanna adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT scisciolalucia adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT rizzomariarosaria adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT surinasurina adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT sarducelestino adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT marfellaraffaele adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT paolissogiuseppe adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism
AT barbierimichelangela adiponectinrelatedvascularandcardiacbenefitsinobesityistherearoleforanepigeneticallyregulatedmechanism